侯遠(yuǎn)鑫 侯淑芬 高榮敏 陳家藝 幸問月 涂星
摘 要 目的:研究蜈蚣草全草石油醚部位的化學(xué)成分。方法:采用硅膠柱色譜、凝膠柱色譜、重結(jié)晶和薄層色譜法對(duì)蜈蚣草全草石油醚部位的化學(xué)成分進(jìn)行分離純化,根據(jù)理化性質(zhì)、氫譜和碳譜數(shù)據(jù)鑒定化合物結(jié)構(gòu)。結(jié)果:從蜈蚣草全草石油醚部位分離、鑒定得到11個(gè)化合物,分別為(2R)-acetyl pterosin B(Ⅰ)、十六烷酸(Ⅱ)、何帕-22(29)-烯(Ⅲ)、表木栓醇(Ⅳ)、羽扇豆酮(Ⅴ)、齊墩果-18-烯-3-酮(Ⅵ)、豆甾醇(Ⅶ)、β-谷甾醇(Ⅷ)、22-羥基何帕烷(Ⅸ)、麥角甾醇(Ⅹ)、β-谷甾醇乙酸酯(Ⅺ)。結(jié)論:化合物Ⅰ~Ⅶ和Ⅸ~Ⅺ為首次從該植物中分離得到,可為深入研究蜈蚣草的生物活性藥效物質(zhì)基礎(chǔ)、豐富其化學(xué)成分研究資料提供理論依據(jù)。
關(guān)鍵詞 蜈蚣草;石油醚部位;化學(xué)成分;何帕-22(29)-烯;齊墩果-18-烯-3-酮;22-羥基何帕烷
Study on Chemical Constituents of Petroleum Ether Part from Whole Herbs of Pteris vittata
HOU Yuanxin1,HOU Shufen2,GAO Rongmin1,CHEN Jiayi1,XING Wenyue1,TU Xing3(1. Dept. of Pharmacy, the Affiliated Minda Hospital of Hubei Minzu University, Hubei Enshi 445000, China; 2. Dept. of Critical Care Medicine, Chongqing Three Gorges Central Hospital, Chongqing 404000, China; 3. College of Medical Science, Hubei Minzu University, Hubei Enshi 445000, China)
ABSTRACT OBJECTIVE: To study the chemical constituents from the petroleum ether part from whole herbs of Pteris vittata. METHODS: The petroleum ether part from whole herbs of P. vittata was separated and isolated by silica gel column, gel column, recrystallization and TLC. The structures of the compounds were identified according to physicochemical properties and spectrum data (1H-NMR and 13C-NMR). RESULTS: A total of 11 compounds were isolated and identified from the petroleum ether part from whole herbs of P. vittata, as (2R)-acetyl pterosin B (Ⅰ), palmitic acid (Ⅱ), hop-22(29)-ene (Ⅲ), epifriedelanol (Ⅳ), lupenone (Ⅴ), olean-18-en-3-one (Ⅵ), stigmasterol (Ⅶ), β-sitosterol (Ⅷ), 22-hydroxyhopane (Ⅸ), ergosterol (Ⅹ), β-sitosterol acetate (Ⅺ). CONCLUSIONS: Compounds Ⅰ-Ⅶ and Ⅸ-Ⅺ are isolated from this plant for the first time, and can provide theoretic reference for further studying bioactive pharmacodynamic substances in P. vittata and enriching chemical component data.
KEYWORDS Pteris vittata; Petroleum ether part; Chemical constituents; Hop-22(29)-ene; Olean-18-en-3-one; 22-hydr- oxyhopane
蜈蚣草(Pteris vittata L.)系鳳尾蕨科(Pteridaceae)鳳尾蕨屬(Pteris L.)植物,別名百足草、蜈蚣蕨、舒筋草等,廣泛分布于我國熱帶和亞熱帶地區(qū),尤其是廣東和廣西地區(qū),常以全草入藥[1]。蜈蚣草具有清熱解毒、消腫止痛、舒筋活絡(luò)的功效,臨床上主要用來治療蜈蚣咬傷、痢疾、風(fēng)濕疼痛、跌打損傷、疥瘡等癥[1-2]。蜈蚣草中主要含有黃酮類和有機(jī)酸類成分,其中黃酮類成分為芹菜素、木犀草素、芹菜素-7-O-β-D-吡喃葡萄糖苷、山柰素-3-O-β-D-吡喃葡萄糖苷、木犀草素-7,3′,4′-三甲醚、3′-甲氧基木犀草素、7-羥基-8-甲氧基香豆素、柯伊利素-7-O-β-D-吡喃葡萄糖苷、紫云英苷等[2-3],其中山柰素-3-O-β-D-吡喃葡萄糖苷具有一定的乙酰膽堿酯酶抑制活性[2];分離鑒定的有機(jī)酸類成分為對(duì)羥基苯甲酸,具有較好的抗菌活性[3]。作為嶺南地區(qū)特色中草藥,蜈蚣草的民間應(yīng)用廣泛、療效顯著,但現(xiàn)有學(xué)成分研究還相對(duì)較少,尚無法為其開發(fā)應(yīng)用提供較好的理論支持。為此,筆者對(duì)蜈蚣草95%乙醇提取物的石油醚部位進(jìn)行了較為系統(tǒng)的化學(xué)成分研究,以期為蜈蚣草的臨床應(yīng)用及藥理活性研究提供參考。
1 材料
1.1 儀器
Bruker AVANCE Ⅲ 500MHz型核磁共振儀(德國Bruker公司);Agilent 6460三重四極桿液質(zhì)聯(lián)用儀(美國Agilent公司);XT4雙目體視顯微熔點(diǎn)測定儀(北京泰克儀器有限公司);RV3型旋轉(zhuǎn)蒸發(fā)儀(德國IKA公司);ME104型分析天平(瑞士Mettler- Toledo公司)。
1.2 藥材
蜈蚣草全草(批號(hào):20130101)于2013年9月由湖北民族大學(xué)附屬民大醫(yī)院侯遠(yuǎn)鑫主管藥師采自于廣西壯族自治區(qū)南寧市興寧區(qū),經(jīng)湖北民族大學(xué)醫(yī)學(xué)院文德鑒副教授鑒定為鳳尾蕨科(Pteridaceae)鳳尾蕨屬(Pteris L.)蜈蚣草(Pteris vittata L.)的全草。
1.3 試劑
柱色譜硅膠(100~200目、200~300目、300~400目,批號(hào)分別為0150054、0140138、0140027)、薄層色譜GF254預(yù)制板(批號(hào):20150406)均由青島海洋化工有限公司提供;Sephadex LH-20凝膠(25~100 μm,批號(hào):10033549,美國Amersham Biosciences公司);β-谷甾醇標(biāo)準(zhǔn)品(中國食品藥品檢定研究院,批號(hào):110851- 201407,純度:98.0%);甲醇、乙腈均為色譜純,石油醚(60~90 ℃)、氯仿、乙酸乙酯等試劑均為化學(xué)純,水為純化水。
2 提取與分離
取蜈蚣草的干燥全草6 kg,粉碎成粗粉后用95%乙醇(20 L)加熱回流提取3次,每次2 h。合并提取液,減壓回收,得黑色總浸膏470 g。將總浸膏充分混懸于純化水2.0 L中,依次用石油醚(6.0 L)、乙酸乙酯(6.0 L)和正丁醇(6.0 L)萃取,相同部位萃取液并減壓回收,得各部位的萃取物。取石油醚部位萃取物105 g,經(jīng)常壓硅膠柱色譜分離,以石油醚-乙酸乙酯(100 ∶ 1、50 ∶ 1、40 ∶ 1、30 ∶ 1、20 ∶ 1、10 ∶ 1、5 ∶ 1、2 ∶ 1,V/V)梯度洗脫,經(jīng)薄層色譜法鑒別后合并,共得到8個(gè)主要流份(Fr.1~Fr.8)。其中,F(xiàn)r.2(6.5 g)依次經(jīng)常壓硅膠柱色譜(石油醚-丙酮,60 ∶ 1、40 ∶ 1、30 ∶ 1、20 ∶ 1、10 ∶ 1、5 ∶ 1、 2 ∶ 1、1 ∶ 1,V/V)梯度洗脫和Sephadex LH-20凝膠柱色譜(氯仿-甲醇,1.5 ∶ 1,V/V)等度洗脫分離得到化合物Ⅰ(11 mg)和化合物Ⅱ(130 mg);Fr.3(1.9 g)依次經(jīng)常壓硅膠柱色譜(石油醚-乙酸乙酯,40 ∶ 1、30 ∶ 1、20 ∶ 1、10 ∶ 1、5 ∶ 1, V/V)梯度洗脫和Sephadex LH-20凝膠柱色譜(氯仿-甲醇,1.5 ∶ 1,V/V)等度洗脫分離,最后通過氯仿重結(jié)晶和制備薄層色譜法(氯仿-甲醇,25 ∶ 1,V/V)得到化合物Ⅲ(39 mg)和化合物Ⅳ(22 mg);Fr.4(7.1 g)依次經(jīng)常壓硅膠柱色譜(石油醚-丙酮,40 ∶ 1、30 ∶ 1、20 ∶ 1、15 ∶ 1、10 ∶ 1、5 ∶ 1,V/V)梯度洗脫、Sephadex LH-20凝膠柱色譜(氯仿-甲醇, 1.5 ∶ 1,V/V)等度洗脫和氯仿重結(jié)晶分離純化得到化合物Ⅴ(8 mg)、化合物Ⅵ(15 mg)、化合物Ⅶ(62 mg)、化合物Ⅷ(200 mg);Fr.5(4.6 g)首先經(jīng)Sephadex LH-20凝膠柱色譜(氯仿-甲醇,1 ∶ 1,V/V)等度洗脫除去大部分色素,然后再依次采用常壓硅膠柱色譜(石油醚-乙酸乙酯,20 ∶ 1、15 ∶ 1、10 ∶ 1、 5 ∶ 1、2 ∶ 1、1 ∶ 1,V/V)等度梯度洗脫和重結(jié)晶法(氯仿-甲醇,1 ∶ 1,V/V)得到化合物Ⅸ(19 mg)、化合物Ⅹ(31 mg)、化合物Ⅺ(40 mg)。
3 結(jié)構(gòu)鑒定
共分離、鑒定出11個(gè)成分,其結(jié)構(gòu)見圖1。
化合物Ⅰ:淡黃色油狀液體(氯仿),分子式:C16H20O3,熔點(diǎn):165~167 ℃,電噴霧質(zhì)譜(ESI-MS):m/z 261[M+H]+。1H-NMR(CDCl3,500 MHz)δ:7.05(1H,s,H-5),4.12(3H,t,J=7.4 Hz,H-12),3.01(2H,t,J=7.4 Hz,H-13),2.43(2H,s,H-14),2.37(3H,s,H-10),2.01(3H,s,H-16),1.23(3H,d,J=7.0 Hz,H-11)。13C-NMR(CDCl3,125 MHz)δ:209.9(C-1),43.3(C-2),34.1(C-3),125.8(C-4),144.4(C-5),134.1(C-6),138.2(C-7),132.7(C-8),153.2(C-9),21.3(C-10),16.8(C-11),28.4(C-12),63.0(C-13),13.7(C-14),171.3(C-15),21.8(C-16)。該化合物波譜數(shù)據(jù)與相關(guān)文獻(xiàn)[4]參考數(shù)據(jù)基本一致,故最終鑒定其為(2R)-acetyl pterosin B。
化合物Ⅱ:白色無定形粉末(氯仿),分子式:C16H32O2,熔點(diǎn):58~60 ℃,ESI-MS:m/z 255[M-H]-。1H-NMR(CDCl3,500 MHz)δ:2.30(2H,t,J=7.1 Hz,H-2),1.59(2H,m,H-3),1.28~1.31(20H,m,H-4~13),1.26(2H,m,H-14),1.23(2H,m,H-15),0.87(3H,t,J=6.9 Hz,H-16)。13C-NMR(CDCl3,150 MHz)δ:179.8(C-1),34.1(C-2),24.6(C-3),29.1(C-4,13),29.3(C-5,12),29.5~29.8(C-6~11),31.7(C-14),22.6(C-15),14.2(C-16)。該化合物波譜數(shù)據(jù)與相關(guān)文獻(xiàn)[5]參考數(shù)據(jù)基本一致,故最終鑒定其為十六烷酸。
化合物Ⅲ:無色針狀晶體(氯仿),分子式:C30H50,熔點(diǎn):233~235 ℃,ESI-MS:m/z 411[M+H]+,10%硫酸乙醇反應(yīng)顯紫紅色。1H-NMR(CDCl3,500 MHz)δ:4.77(2H,s,H-29),1.75(3H,s,H-30),0.98(3H,s,H-26),0.96(3H,s,H-27),0.85(3H,s,H-23),0.84(3H,s,H-25),0.80(3H,s,H-24),0.74(3H,s,H-28)。13C-NMR(CDCl3,125 MHz)δ:40.4(C-1),19.2(C-2),42.2(C-3),33.3(C-4,C-7),56.4(C-5),20.0(C-6),41.9(C-8),50.6(C-9),37.4(C-10),21.0(C-11),24.0(C-12),49.6(C-13),42.0(C-14),33.7(C-15),21.7(C-16),54.9(C-17),44.7(C-18),41.9(C-19),27.4(C-20),46.5(C-21),148.7(C-22),33.4(C-23),21.6(C-24),16.1(C-25),16.8(C-26),17.0(C-27),16.9(C-28),110.3(C-29),25.1(C-30)。該化合物波譜數(shù)據(jù)與相關(guān)文獻(xiàn)[6]參考數(shù)據(jù)基本一致,故最終鑒定其為何帕-22(29)-烯。
化合物Ⅳ:白色無定形粉末(氯仿),分子式:C30H52O,熔點(diǎn):268~270 ℃,ESI-MS:m/z 427[M-H]-,10%硫酸乙醇反應(yīng)顯紫紅色。1H-NMR(CDCl3,500 MHz)δ:3.73(1H,d,J=2.6 Hz,H-3),1.44(1H,t,J=5.1 Hz,H-18),0.99(3H,s,H-26),0.97(3H,s,H-28),0.92(3H,s,H-27),0.90(3H,s,H-24),0.89(3H,s,H-29),0.86(3H,s,H-25)。13C-NMR(CDCl3,125 MHz)δ:15.7(C-1),35.0(C-2),73.0(C-3),49.2(C-4),36.5(C-5),41.5(C-6),17.5(C-7),53.0(C-8),38.1(C-9),61.2(C-10),35.2(C-11),30.2(C-12),37.9(C-13),39.5(C-14),32.0(C-15),36.4(C-16),30.9(C-17),42.6(C-18),35.8(C-19),29.0(C-20),33.1(C-21),39.0(C-22),11.2(C-23),16.4(C-24),18.0(C-25),18.1(C-26),20.0(C-27),30.5(C-28),35.3(C-29),31.8(C-30)。該化合物波譜數(shù)據(jù)與相關(guān)文獻(xiàn)[7]參考數(shù)據(jù)基本一致,故最終鑒定其為表木栓醇。
化合物Ⅴ:白色無定形粉末(氯仿),分子式:C30H48O,熔點(diǎn):179~181 ℃,ESI-MS:m/z 425[M+H]+,10%硫酸乙醇反應(yīng)顯紫紅色。1H -NMR(CDCl3,500 MHz)δ:4.72(2H,s,H-29),1.55(3H,s,H-30),1.07(3H,s,H-26),1.01(3H,s,H-23),0.95(3H,s,H-27),0.92(3H,s,H-25),0.88(3H,s,H-28),0.75(3H,s,H-24)。13C-NMR(CDCl3,125 MHz)δ:39.4(C-1),34.5(C-2),218.0(C-3),47.0(C-4),55.1(C-5),19.8(C-6),33.5(C-7),40.5(C-8),50.3(C-9),36.8(C-10),21.1(C-11),25.0(C-12),37.0(C-13),43.0(C-14),27.3(C-15),35.6(C-16),43.1(C-17),48.0(C-18),47.5(C-19),151.3(C-20),29.7(C-21),40.9(C-22),26.5(C-23),21.0(C-24),15.8(C-25),15.5(C-26),15.1(C-27),18.0(C-28),109.0(C-29),19.5(C-30)。該化合物波譜數(shù)據(jù)與相關(guān)文獻(xiàn)[8]參考數(shù)據(jù)基本一致,故最終鑒定其為羽扇豆酮。
化合物Ⅵ:白色無定形粉末(氯仿),分子式:C30H48O,熔點(diǎn):182~184 ℃,ESI-MS:m/z 448[M+Na]+,10%硫酸乙醇反應(yīng)顯紫紅色。1H -NMR(CDCl3,500 MHz)δ:5.08(1H,s,H-19),1.12(3H,s,H-26),1.06(3H,s,H-28),1.02(3H,s,H-23),0.99(3H,s,H-29),0.96(3H,s,H-30),0.93(3H,s,H-25),0.83(3H,s,H-24),0.79(3H,s,H-27)。13C-NMR(CDCl3,125 MHz)δ:38.5(C-1),34.3(C-2),219.1(C-3),47.9(C-4),55.0(C-5),19.8(C-6),32.4(C-7),40.3(C-8),47.2(C-9),37.3(C-10),21.0(C-11),26.4(C-12),39.4(C-13),43.5(C-14),27.5(C-15),37.1(C-16),35.0(C-17),143.0(C-18),129.5(C-19),32.0(C-20),33.8(C-21),37.5(C-22),27.4(C-23),15.3(C-24),17.0(C-25),16.2(C-26),14.7(C-27),26.0(C-28),33.4(C-29),23.3(C-30)。該化合物波譜數(shù)據(jù)與相關(guān)文獻(xiàn)[9]參考數(shù)據(jù)基本一致,故最終鑒定其為齊墩果-18-烯-3-酮。
化合物Ⅶ:白色針狀結(jié)晶(氯仿),分子式:C29H48O,熔點(diǎn):160~162 ℃,ESI-MS:m/z 411[M-H]-,10%硫酸乙醇反應(yīng)顯紫紅色。1H -NMR(CDCl3,500 MHz)δ:5.12(1H,dd,J=8.5,15.3 Hz,H-22),5.00(1H,dd,J=8.5,15.4 Hz,H-23),3.49(1H,t-like,H-3)。13C-NMR(CDCl3,150 MHz)δ:37.1(C-1),31.5(C-2),71.6(C-3),42.5(C-4),140.9(C-5),122.0(C-6),40.3(C-7),31.9(C-8),50.0(C-9),36.1(C-10),20.9(C-11),39.4(C-12),42.1(C-13),56.8(C-14),22.7(C-15),28.6(C-16),56.3(C-17),12.1(C-18),21.0(C-19),40.3(C-20),19.0(C-21),138.1(C-22),129.4(C-23),51.3(C-24),29.0(C-25),19.1(C-26),20.6(C-27),24.3(C-28),11.8(C-29)。該化合物波譜數(shù)據(jù)與相關(guān)文獻(xiàn)[9-10]參考數(shù)據(jù)基本一致,故最終鑒定其為豆甾醇。
化合物Ⅷ:無色針狀結(jié)晶(氯仿),分子式:C29H50O,熔點(diǎn):140~142 ℃,ESI-MS:m/z 413[M-H]-,10%硫酸乙醇反應(yīng)顯紫紅色。與β-谷甾醇標(biāo)準(zhǔn)品薄層對(duì)照,在3種展開系統(tǒng)[石油醚-乙酸乙酯(10 ∶ 1,V/V)、石油醚-丙酮(10 ∶ 1,V/V)、氯仿-甲醇(15 ∶ 1,V/V)]中的比移值一致,且其與β-谷甾醇標(biāo)準(zhǔn)品混合后,熔點(diǎn)不下降,故最終鑒定其為β-谷甾醇。
化合物Ⅸ:白色針狀結(jié)晶(氯仿),分子式:C30H52O,熔點(diǎn):227~229 ℃,ESI-MS:m/z 427[M-H]-,10%硫酸乙醇反應(yīng)顯紫紅色。1H -NMR(CDCl3,500 MHz)δ:1.26(3H,s,H-30),1.15(3H,s,H-29),0.91(3H,s,H-26),0.91(3H,s,H-27),0.83(3H,s,H-23),0.80(3H,s,H-25),0.76(3H,s,H-24),0.73(3H,s,H-28)。13C-NMR(CDCl3,125 MHz)δ:40.1(C-1),18.6(C-2,C-6),42.5(C-3),33.3(C-4),56.0(C-5),33.1(C-7),42.3(C-8),50.3(C-9),37.3(C-10),19.6(C-11),24.5(C-12),49.9(C-13),42.5(C-14),34.1(C-15),22.0(C-16),54.4(C-17),44.0(C-18),41.2(C-19),24.5(C-20),51.1(C-21),74.0(C-22),28.6(C-23),21.5(C-24),15.9(C-25),17.0(C-26),17.0(C-27),16.0(C-28),42.5(C-29),29.9(C-30)。該化合物波譜數(shù)據(jù)與相關(guān)文獻(xiàn)[6]參考數(shù)據(jù)基本一致,故最終鑒定其為22-羥基何帕烷。
化合物Ⅹ:無色針狀晶體(氯仿),分子式:C28H44O,熔點(diǎn):168~170 ℃,ESI-MS:m/z 395[M-H]-,10%硫酸乙醇反應(yīng)顯紫紅色。1H-NMR(CDCl3,500 MHz)δ:5.47(1H,dd,J=2.1,5.8 Hz,H-6),5.30(1H,m,H-7),3.63(1H,m,H-3),1.00(3H,d,J=5.8 Hz,H-21),0.95(3H,s,H-19),0.90(3H,d,J=6.4 Hz,H-28),0.81(3H,d,J=5.9 Hz,H-27),0.65(3H,s,H-18)。13C-NMR(CDCl3,125 MHz)δ:38.1(C-1),32.1(C-2),70.3(C-3),40.9(C-4),140.1(C-5),119.9(C-6),116.5(C-7),141.0(C-8),46.2(C-9),37.0(C-10),21.3(C-11),38.8(C-12),41.4(C-13),54.6(C-14),23.1(C-15),28.0(C-16),55.6(C-17),12.1(C-18),17.5(C-19),40.5(C-20),21.3(C-21),135.5(C-22),132.1(C-23),39.3(C-24),33.0(C-25),19.8(C-26),19.6(C-27),16.3(C-28)。該化合物波譜數(shù)據(jù)與相關(guān)文獻(xiàn)[11]參考數(shù)據(jù)基本一致,故最終鑒定其為麥角甾醇。
化合物Ⅺ:白色針狀結(jié)晶(氯仿),分子式:C31H52O2,熔點(diǎn):136~138 ℃,ESI-MS:m/z 457[M+H]+,10%硫酸乙醇反應(yīng)顯紫紅色。1H -NMR(CDCl3,500 MHz)δ:5.38(1H,d,J=5.0 Hz,H-6),4.57(1H,m,H-3),1.00(3H,s,H-19),0.95(3H,d,J=6.2 Hz,H-21),0.83(9H,m,H-26,27,29),0.63(3H,s,H-18)。13C-NMR(CDCl3,125 MHz)δ:36.6(C-1),32.2(C-2),74.1(C-3),39.9(C-4),140.3(C-5),122.7(C-6),31.6(C-7),31.9(C-8),50.0(C-9),36.1(C-10),21.3(C-11),38.0(C-12),42.2(C-13),56.7(C-14),24.0(C-15),29.5(C-16),56.0(C-17),12.1(C-18),19.1(C-19),36.0(C-20),19.1(C-21),33.9(C-22),27.9(C-23),46.1(C-24),29.0(C-25),20.1(C-26),18.8(C-27),22.9(C-28),12.3(C-29),170.2(C-30),21.2(C-31)。該化合物波譜數(shù)據(jù)與相關(guān)文獻(xiàn)[12]參考數(shù)據(jù)基本一致,故最終鑒定其為β-谷甾醇乙酸酯。
4 討論
本研究從蜈蚣草全草95%乙醇提取物的石油醚部位中共分離得到11個(gè)化合物,經(jīng)鑒定分別為(2R)-acetyl pterosin B(Ⅰ)、十六烷酸(Ⅱ)、何帕-22(29)-烯(Ⅲ)、表木栓醇(Ⅳ)、羽扇豆酮(Ⅴ)、齊墩果-18-烯-3-酮(Ⅵ)、豆甾醇(Ⅶ)、β-谷甾醇(Ⅷ)、22-羥基何帕烷(Ⅸ)、麥角甾醇(Ⅹ)、β-谷甾醇乙酸酯(Ⅺ)?;衔铫駷楸栋胼祁惓煞?,化合物Ⅱ?yàn)橹舅犷惓煞?,化合物Ⅲ、Ⅳ、Ⅴ、Ⅵ、Ⅸ為三萜類成分,化合物Ⅶ、Ⅷ、Ⅹ、Ⅺ為甾體類成分;化合物Ⅰ~Ⅶ和Ⅸ~Ⅺ為首次從蜈蚣草中分離得到。本研究首次從蜈蚣草全草中分離鑒定出倍半萜類成分(Ⅰ)、何帕烷型三萜類成分(Ⅲ和Ⅸ)、齊墩果烷型三萜類成分(Ⅵ),在較大程度上豐富了其化學(xué)成分研究成果,可為深入研究其藥效物質(zhì)基礎(chǔ)提供了一定的理論依據(jù)。
參考文獻(xiàn)
[ 1 ] 謝宗萬.全國中草藥匯編[M].北京:人民衛(wèi)生出版社,1996:646-647.
[ 2 ] 殷帥文,胡文杰,葉飛飛,等.蜈蚣草化學(xué)成分及抑制乙酰膽堿酯酶生物活性研究[J].天然產(chǎn)物研究與開發(fā),2018,30(8):1367-1370.
[ 3 ] 侯遠(yuǎn)鑫,周昌園,侯淑芬,等.蜈蚣草乙酸乙酯部位化學(xué)成分分離鑒定[J].中國實(shí)驗(yàn)方劑學(xué)雜志,2018,24(19):52-55.
[ 4 ] WANG YS,LI FY,HUANG R,et al. Chemical constituents of Pteris multifida[J]. Chem Nat Compd,2013,49(4):629-631.
[ 5 ] 高建華,楊婷,董玉.蒙藥復(fù)方協(xié)日嘎四味湯散的化學(xué)成分研究[J].中國藥房,2014,25(47):4470-4472.
[ 6 ] 楊寶,范真,朱錦萍,等.金雞腳化學(xué)成分研究[J].中草藥,2014,45(21):3053-3056.
[ 7 ] 張慧穎,付興情,蔡義玲,等.大理衛(wèi)矛乙醇提取物的化學(xué)成分研究[J].中國藥房,2018,29(2):176-179.
[ 8 ] 張擴(kuò),趙明,王美嬌,等.細(xì)葉杜香葉中三萜類化學(xué)成分研究[J].中草藥,2018,49(6):1250-1254.
[ 9 ] 錢春香,孫麗娜,薛璇璣,等.乳苣全草石油醚部位化學(xué)成分的研究[J].中草藥,2017,48(7):1302-1305.
[10] 趙震宇,羅寧,陳晨,等.單針藻的化學(xué)成分及其體外抗菌、抗氧化活性研究[J].中國藥房,2017,28(4):465-468.
[11] 黃周鋒,黃建猷,盧文杰,等.裸花水竹草化學(xué)成分[J].中國實(shí)驗(yàn)方劑學(xué)雜志,2016,22(21):73-76.
[12] 郭志俊,楊竹雅,譚文紅,等.制黃草烏化學(xué)成分研究[J].中藥材,2015,38(5):988-991.
(收稿日期:2018-09-13 修回日期:2019-02-20)
(編輯:余慶華)